The Cystic Fibrosis Mutation G551D Alters the Non-Michaelis-Menten Behavior of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel and Abolishes the Inhibitory Genistein Binding Site
Open Access
- 1 September 2002
- journal article
- Published by Elsevier
- Vol. 277 (39) , 35999-36004
- https://doi.org/10.1074/jbc.m206121200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- ATP Hydrolysis by a CFTR Domain: Pharmacology and Effects of G551D MutationBiochemical and Biophysical Research Communications, 2000
- Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl− channels expressed in murine cell lineThe Journal of Physiology, 2000
- Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genisteinBiochemical Journal, 1999
- ATPase Activity of the Cystic Fibrosis Transmembrane Conductance RegulatorJournal of Biological Chemistry, 1996
- The Prothrombinase Reaction: “Mechanism Switching” between Michaelis−Menten and Non-Michaelis−Menten BehaviorsBiochemistry, 1996
- Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.Journal of Clinical Investigation, 1994
- Lower efficacy: interaction with an inhibitory receptor or partial agonism?Trends in Pharmacological Sciences, 1994
- Phosphorylation-regulated CI− channel in CHO cells stably expressing the cystic fibrosis geneNature, 1991
- A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator proteinNature, 1990
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989